They’re tiny drug-delivery systems 1000 times smaller than a human hair, but while nanomedicines have long been hailed as the future for treating debilitating and life-threatening diseases, their journey from lab to patient has many challenges.
Clinical Trial Payments: Optimizing the Path Forward for Site Payments
Jim DiCesare, Sr. Director, Study Operations, IQVIA Clinical Trial Payments Escalating competition for clinical trial sites, in tandem with other industry-wide challenges such as changing